A detailed history of Elgethun Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Elgethun Capital Management holds 4,267 shares of PFE stock, worth $113,587. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,267
Previous 5,305 19.57%
Holding current value
$113,587
Previous $148,000 16.89%
% of portfolio
0.03%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $28,752 - $32,582
-1,038 Reduced 19.57%
4,267 $123,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $1,465 - $1,716
58 Added 1.11%
5,305 $148,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $3,262 - $3,745
126 Added 2.46%
5,247 $145,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $66,618 - $77,870
-2,076 Reduced 28.85%
5,121 $169,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $3,539 - $4,095
98 Added 1.38%
7,197 $263,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $125,851 - $163,839
-3,195 Reduced 31.04%
7,099 $289,000
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $157,230 - $205,247
-3,766 Reduced 26.79%
10,294 $527,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $134,955 - $164,747
3,084 Added 28.1%
14,060 $615,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $3,722 - $4,413
80 Added 0.73%
10,976 $574,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $7,137 - $8,843
-156 Reduced 1.41%
10,896 $564,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $6,280 - $9,310
-152 Reduced 1.36%
11,052 $630,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $15,111 - $19,411
385 Added 3.56%
11,204 $482,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $3,483 - $3,945
97 Added 0.9%
10,819 $424,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $17,113 - $19,300
-511 Reduced 4.55%
10,722 $388,000
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $95,958 - $122,019
2,867 Added 34.27%
11,233 $413,000
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $5,919 - $8,457
219 Added 2.69%
8,366 $273,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $1,848 - $2,076
-50 Reduced 0.61%
8,147 $353,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $19,235 - $21,930
-500 Reduced 5.75%
8,197 $355,000
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $9,893 - $10,547
300 Added 3.57%
8,697 $315,000
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $20,422 - $23,692
640 Added 8.25%
8,397 $298,000
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $257,997 - $273,744
7,757
7,757 $281,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Elgethun Capital Management Portfolio

Follow Elgethun Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.